News

Perrigo’s partner Synthon has filed an ANDA for Levocetirizine solution 2.5mg/5ml, a generic version of Xyzal solution 2.5mg/5ml. Xyzal solution 2.5mg/5ml is meant for the treatment of allergies

Financial Highlights Operating profit increased 17.9% to $13.2 million (2008: $11.2 million) EBITDA increased 13.9% to $15.6 million (2008: $13.7 million) and EBITDA margin increased to 29.7% (2008:

TriLink has signed a sales and license agreement with Glen Research to sell TriLink’s CleanAmp Amidites. Glen Research can now sell the patented CleanAmp Amidites to third parties

Actavis has launched Finasteride in France, just one day before the patent expired. The distribution of the product has already been initiated. Finasteride Actavis was launched by the

CEL-SCI has filed a provisional US patent application covering its LEAPS immune therapy drugs (vaccines). It is intended for the prevention/treatment of H1N1, swine flu, bird flu, Influenza

Gentiva Health Services, a provider of comprehensive home health services, has acquired Mid-State Home Health in Louisiana. Tony Strange, President and CEO, Gentiva, said Combining forces with Mid-State

Cell Therapeutics (CTI) has completed the submission of New Drug Application (NDA) to the FDA for pixantrone. It is intended to treat relapsed or refractory, aggressive non-Hodgkin’ lymphoma

Conatus Pharmaceuticals (Conatus) has initiated the second phase-II clinical trial with a drug candidate, for the treatment of liver disease associated with Hepatitis C Virus (HCV) infection. The

Takeda has completed the acquisition of IDM Pharma for $2.64 per share in cash, through a short-form merger of Jade, a wholly-owned subsidiary of Takeda, into IDM. With